Gogin Capital

WAmazing provides free subscriber identification module (SIM) cards that allow foreign travelers to register before their arrival in Japan. Through an app, WAmazing also provides tourists with free internet services of up to 500MB. The service aims to prevent visitors from being locked out of free wifi because of sign-up pages in Japanese that demand a local phone number. WAmazing was founded in 2016 and is based in Tokyo, Japan.

BeBit is a consulting firm that provides customer experience management and user-centered design support services.

PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.The company leverages technology to develop rapidly changing cell therapies and mesenchymal stem cells therapies, enabling clients to fight a variety of diseases and change the future of transplantation medicine.

S-Nanotech Co-Creation is a manufacture and sale of functional materials and their related devices and equipment and it is a design, manufacture and sale of machinery, optical equipment, electronic equipment, analytical equipment and their components.

mAbProtein is a research and develop, manufacture, and sell research reagents, diagnostics, and pharmaceuticals that utilize the research seeds (special antibody production technology) of Prof.

On the way to Sakano deliver vegetables grown without the use of pesticides and chemical fertilizers, aiming to spread agriculture with low environmental impact. We want to make agriculture sustainable and reach a sustainable society.

Headquartered in Shibuya-ku, Tokyo, Monstar Lab, Inc. provides access to top talent and specialists around the world as the foundation for all of the group’s activities. The company consists of more than 1200 engineers and creators in offices in 26 cities and 15 countries worldwide. The core consultancy arm of the company engineers awesome solutions that perform for clients around the world. In addition, the company’s array of products and services ranging from co-working spaces, robotic process automation, game development, streaming services, HR tech and education programs empower thinkers and makers globally.

Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.

PuREC is a developer of a culture technology intended to bring efficacy to the treatment process.The company leverages technology to develop rapidly changing cell therapies and mesenchymal stem cells therapies, enabling clients to fight a variety of diseases and change the future of transplantation medicine.